Isabella Ogorek

Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia

Melanie Hüttenrauch, Isabella Ogorek, Hans‐Wolfgang Klafki et al. · Acta Neuropathologica Communications · 2018 · 173 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Blood Platelets in the Progression of Alzheimer’s Disease

Nina Sarah Gowert, L Donner, Madhumita Chatterjee et al. · PLoS ONE · 2014 · 142 citations · Full text

Medicine, Neurology, Neuroscience +17

The metalloprotease ADAMTS4 generates N-truncated Aβ4–x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer’s disease

Susanne Walter, Thorsten Jumpertz, Melanie Hüttenrauch et al. · Acta Neuropathologica · 2018 · 68 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma <i>in vitro</i>

Abigail K. Suwala, Katharina Koch, Dayana Herrera Rios et al. · Oncotarget · 2018 · 62 citations · Full text

Medicine, Oncology, Pharmacology +16

Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors

Parul Goel, Thorsten Jumpertz, Anežka Tichá et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12